Understanding Your Weight Loss Treatment Switch Options
Can I Switch From Wegovy To Mounjaro: Key Treatment Differences
When considering whether you can switch from Wegovy to Mounjaro, understanding the fundamental differences between these prescription weight loss treatments is crucial. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, which works as both a GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) dual receptor agonist. This dual mechanism may provide different appetite control effects, though both medicines are designed to support weight management alongside a reduced-calorie diet and increased physical activity.
The decision to switch from Wegovy to Mounjaro requires careful clinical assessment, as each treatment has distinct dosing schedules and potential side effect profiles. Wegovy follows a structured 5-dose escalation over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, to 2.4mg maintenance), while Mounjaro has a different titration schedule starting at 2.5mg weekly. Your prescriber will need to determine the appropriate starting dose for Mounjaro based on your current Wegovy dose and individual response to treatment. At EverydayMeds, our clinical team can guide this transition through a comprehensive reassessment process.
Switching From Wegovy To Mounjaro: Pricing And Treatment Value
Understanding the cost implications when you switch from Wegovy to Mounjaro can help inform your treatment decision. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, with our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) available for £169.99. The maintenance 2.4mg dose costs £209.99, or you can secure three months' supply with our Ultimate Stability Trio for £649.99. New customers receive code FIRST40 at checkout, while returning customers use DOSE25.
When considering whether you can switch from Wegovy to Mounjaro, factor in the different storage requirements alongside cost. Wegovy offers superior travel convenience with 6 weeks room temperature storage (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers or those with limited refrigerator access. Both treatments require ongoing prescription-only medicine supply through licensed pharmacies like EverydayMeds (GPhC #9012878), ensuring consistent clinical oversight throughout your weight management journey.
Clinical Evidence For Switching Weight Loss Treatments
The decision to switch from Wegovy to Mounjaro should be based on robust clinical evidence from their respective licensing trials. Wegovy demonstrated significant weight management support in the landmark STEP programme, with the primary STEP 1 trial showing participants achieved approximately 15% average weight loss at 68 weeks when used alongside lifestyle interventions (Wilding et al., NEJM, 2021). The STEP trials also demonstrated sustained weight management at 2 years and cardiovascular benefits in the SELECT trial.
Mounjaro's clinical programme (SURMOUNT trials) evaluated tirzepatide's dual GIP/GLP-1 mechanism in weight management, though direct head-to-head comparisons with Wegovy haven't been conducted in identical trial populations. When considering whether you can switch from Wegovy to Mounjaro, your prescriber will evaluate your individual response to current treatment, any side effects experienced, and your specific weight management goals. Both treatments require ongoing medical supervision as prescription-only medicines.
How Wegovy Works In Your Weight Management Journey
Understanding Wegovy's mechanism helps clarify why some patients consider switching treatments. As a GLP-1 receptor agonist, Wegovy mimics the action of glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This hormone signals to your brain's appetite control centres, promoting feelings of fullness and reducing food cravings between meals. The once-weekly FlexTouch injection delivers consistent semaglutide levels, supporting appetite regulation throughout the week. Wegovy may also slow gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety after smaller portions. This comprehensive appetite control mechanism, combined with reduced-calorie diet and increased physical activity, forms the foundation of Wegovy's weight management approach.
Your Treatment Switching Process At EverydayMeds
If you're wondering whether you can switch from Wegovy to Mounjaro, EverydayMeds streamlines this transition through our comprehensive clinical assessment process. Our 3-minute online evaluation captures your current treatment history, response to Wegovy, any side effects experienced, and your weight management goals. Our prescribers typically complete treatment reviews within 3 working days (24-hour express service available), ensuring thorough evaluation of your switching request. Once approved for Mounjaro or continued Wegovy treatment, we provide next-day cold-chain delivery maintaining the 2-8°C temperature requirements throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all prescription-only medicines meet UK pharmaceutical standards, with ongoing clinical support throughout your treatment journey.
Storage And Practical Considerations When Switching Treatments
Practical storage differences may influence your decision when you consider switching from Wegovy to Mounjaro. Both treatments require refrigerated storage at 2-8°C before first use, but Wegovy offers superior room temperature stability once removed from the fridge. Wegovy pens can be stored at room temperature (below 30°C) for up to 6 weeks, whilst Mounjaro has a 21-day room temperature limit. This extended stability makes Wegovy particularly convenient for business travel, holidays, or situations where refrigerated storage isn't readily available. Both treatments use pre-filled injection pens with different mechanisms - Wegovy uses the FlexTouch system whilst Mounjaro employs KwikPen technology. Your prescriber will provide comprehensive injection training regardless of which treatment you choose, ensuring confident self-administration throughout your weight management programme.
Personalised Weight Loss Treatment Selection
The question "can I switch from Wegovy to Mounjaro" reflects the personalised nature of modern weight management medicine. Some patients consider switching due to side effect profiles, as the dual GIP/GLP-1 mechanism in Mounjaro may produce different gastrointestinal effects compared to Wegovy's GLP-1-only action. Others evaluate switching based on dosing convenience, treatment response, or storage requirements fitting their lifestyle. Your individual medical history, including any diabetes, cardiovascular conditions, or previous weight loss treatment responses, influences which prescription weight loss medicine may be most suitable.
At EverydayMeds, we recognise that weight management is a highly individual journey requiring personalised clinical support. Our prescribers evaluate multiple factors when considering treatment switches, including your BMI trajectory on current treatment, tolerance of side effects, and long-term weight management goals. Both Wegovy and Mounjaro are available through our platform, allowing flexibility to optimise your treatment based on clinical response and personal circumstances. This comprehensive approach ensures your weight loss treatment aligns with your individual needs and preferences.
Secure Your Prescription Weight Loss Treatment Today
Ready to explore whether you can switch from Wegovy to Mounjaro, or continue with optimised Wegovy treatment? EverydayMeds makes accessing prescription weight loss medicine straightforward through our clinical assessment process. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 for discounted pricing starting from £79.99. Our comprehensive treatment bundles, including the convenient Intro Duo for £169.99, provide seamless treatment progression with assured cold-chain delivery. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, or contact our team for personalised treatment guidance. Our commitment to accessible, clinically-supervised weight management ensures you receive optimal prescription-only medicine support throughout your journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
